Tony Butler
Stock Analyst at Rodman & Renshaw
(0.77)
# 4,093
Out of 5,180 analysts
88
Total ratings
34.33%
Success rate
-16.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $4.73 | +428.54% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $1.79 | +514.53% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.53 | +1,076.47% | 4 | Sep 26, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $2.26 | +607.96% | 5 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.20 | +733.33% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $47.57 | +57.66% | 8 | Aug 8, 2023 | |
| GTBP GT Biopharma | Reiterates: Hold | $60 | $0.41 | +14,602.28% | 5 | Aug 7, 2023 | |
| CGEN Compugen | Reiterates: Buy | $13 | $2.13 | +510.33% | 6 | Aug 7, 2023 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $50 | $4.64 | +977.59% | 5 | Aug 3, 2023 | |
| ALLO Allogene Therapeutics | Reiterates: Buy | $15 | $2.44 | +514.75% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.16 | +15,427.95% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.46 | +927.40% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.21 | +211.53% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $0.54 | +3,048.15% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $3.34 | +4,870.06% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $7.65 | +684.31% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $1.48 | +16,116.22% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.20 | +2,870.30% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $0.36 | +99,900.00% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $2.54 | -21.26% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.67 | +2,132.48% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.30 | +669.23% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $5.29 | +183.55% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $12.82 | +758.03% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $10.68 | +8,888.76% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $4.73
Upside: +428.54%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $1.79
Upside: +514.53%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.53
Upside: +1,076.47%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $2.26
Upside: +607.96%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.20
Upside: +733.33%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $47.57
Upside: +57.66%
GT Biopharma
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.41
Upside: +14,602.28%
Compugen
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $2.13
Upside: +510.33%
Bicycle Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $4.64
Upside: +977.59%
Allogene Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $2.44
Upside: +514.75%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.16
Upside: +15,427.95%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.46
Upside: +927.40%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $3.21
Upside: +211.53%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $0.54
Upside: +3,048.15%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $3.34
Upside: +4,870.06%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $7.65
Upside: +684.31%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $1.48
Upside: +16,116.22%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.20
Upside: +2,870.30%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $0.36
Upside: +99,900.00%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $2.54
Upside: -21.26%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $0.67
Upside: +2,132.48%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.30
Upside: +669.23%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $5.29
Upside: +183.55%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $12.82
Upside: +758.03%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $10.68
Upside: +8,888.76%